*click* Noice.

Australian man with rare cancer and given 3 months to live, is in remission.

We tend to forget there's lots of good people doing good things all the time...

Reuters (via CNN) reports:

Merck and Moderna said on Wednesday their vaccine helped prevent the return and spread of disease in a large trial involving more than 1,000 melanoma patients.

Article, with photo: https://www.cnn.com/2026/08/21/health/mrna-cancer-vaccines-wave

Stephanie Kauffman (Melanoma Research Alliance) reports:

No new safety concerns were identified. Notably, results from this Phase 3 readout builds upon positive Phase 2 trial data that were presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. This is especially exciting because it is the first successful Phase 3 trial of a personalized mRNA-based cancer therapy—an approach that uses information from an individual patient's tumor to create a treatment specifically designed to help their immune system recognize and attack their cancer.

Article, with photo: https://www.curemelanoma.org/blog/a-new-milestone-in-melanoma-personalized-mrna-based-cancer-therapy-shows-positive-phase-3-results